Analyst Ranking
Bottom 3%
#5117 out of 5226 analysts
Average Return
-10.46%
Win Rate
30%38 out of 126
Risk vs Reward
Poor
Good

David Turkaly's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neuronetics IncSTIM
+366.27%$0.83$3.87
2024-08-14 -
2025-08-13
Buy
Icad IncICAD
+99.77%$8.88$17.74
2020-02-05 -
2021-02-05
Buy
Lantheus Holdings IncLNTH
+67.88%$64.32$107.98
2023-11-03 -
2024-11-01
Buy
Axogen IncAXGN
+60.46%$18.21$29.22
2025-03-05 -
2026-03-04
Buy
Paragon 28 IncFNA
+58.67%$8.25$13.09
2024-05-09 -
2025-04-17
Buy

David Turkaly's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Lantheus Holdings IncLNTH
11Buy$85.00+14.49%Maintains
a month ago
Axogen IncAXGN
7Buy$42.00+28.79%Maintains
a month ago
Mimedx Group IncMDXG
1Buy$10.00+142.13%Initiates Coverage On
a month ago
Stryker CorpSYK
1Buy$440.00+33.94%Upgrades
3 months ago
Tela Bio IncTELA
7Buy$5.00+557.03%Maintains
4 months ago
Apyx Medical CorpAPYX
2Buy$8.00+103.05%Upgrades
4 months ago
Orthopediatrics CorpKIDS
12Buy$25.00+57.13%Maintains
6 months ago
Haemonetics CorpHAE
9Buy$100.00+76.49%Reiterates
10 months ago
Steris PLCSTE
15Buy$280.00+26.28%Maintains
10 months ago
Integra Lifesciences Holdings CorpIART
13Buy$25.00+162.05%Maintains
a year ago
Enovis CorpENOV
2Buy$55.00+148.76%Maintains
a year ago
Zimmer Biomet Holdings IncZBH
11Buy$125.00+44.81%Maintains
a year ago
Crowdstrike Holdings IncCRWD
1Buy$500.00+27.23%Maintains
a year ago
Si Bone IncSIBN
6Buy$32.00N/AReiterates
a year ago
Snap IncSNAP
1Buy$16.00N/AReiterates
a year ago
Neuronetics IncSTIM
4Buy$3.00N/AMaintains
2 years ago
Paragon 28 IncFNA
4Buy$20.00N/AMaintains
2 years ago
Teleflex IncTFX
10Buy$285.00N/AReiterates
2 years ago
Nevro CorpNVRO
5Buy$40.00N/AMaintains
3 years ago
Icad IncICAD
4Buy$4.00N/AMaintains
3 years ago
Cognyte Software LtdCGNT
1Buy$5.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.